Monday, 22 October 2012 13:35
Mark Galland, MD, a physician with Orthopaedic Specialists of North Carolina, has released a podcast discussing chronic musculoskeletal injuries and treating overuse with platelet-rich plasma therapy.
Published in Pain Management
Tuesday, 10 April 2012 14:45
Biotechnology company Arteriocyte has received approval from the Food and Drug Administration to initiate a Phase I clinical trial with its Magellan MAR01 technology for treating compartment syndrome in extremity trauma patients.
Monday, 02 April 2012 15:22
Robert LaPrade, MD, a knee surgeon at The Steadman Clinic and chief medical research officer for the Steadman Philippon Research Institute in Vail, Colo., hosted and co-chaired the Biologic Treatments for Sports Injuries Symposium in early March.
Tuesday, 21 February 2012 21:08
A recent study conducted in India showed that platelet-rich plasma can enhance the rate of union among patients with non-united long bone fractures, according to an AAOS Now report.
Monday, 13 February 2012 21:10
Orthopedic surgeons and researchers found that platelet-rich plasma can produce improvement in patients who suffer from elbow injury after conservative treatments fail, according to a news release from the American Orthopaedic Society for Sports Medicine.
Tuesday, 07 February 2012 15:35
CONMED has announced it will launch several new sports medicine devices over the next week, according to a company news release.
Friday, 20 January 2012 19:42
The American Academy of Orthopaedic Surgeons has added a new annual meeting symposium titled "Should I Use Platelet-Rich Plasma for My Patients in the Office and Operating Room?," according to an organization report.
Wednesday, 11 January 2012 17:01
ThermoGenesis, a Rancho Cordova, Calif.-based medical device company, recently partnered with Arthrex to market the ThermoGenesis Res-Q 60 System for preparing autologous platelet-rich plasma and bone marrow concentrate, according to a company news release.
Friday, 06 January 2012 16:44
Wayne, N.J.-based medical device company Cascade Medical Enterprises has sold its technology for platelet-rich plasma and platelet-rich fibrin matrix to Musculoskeletal Transplant Foundation, according to a Cascade Medical news release.
Thursday, 29 December 2011 17:48
Top sports medicine physicians and specialists discuss the most important technology and techniques revolutionizing their practices today and where sports medicine is headed in the future.